Depression in patients with polycystic ovary syndrome: a descriptive two-phase (prospective) study


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. In the light of the transformation of scientific views on the problem of polycystic ovary syndrome (PCOS), the evaluation of the relationship between the mental and physical condition of patients, including in planning a pregnancy, take on great importance. Objective. Evaluation of the frequency and features of mood disorders in patients with PCOS seeking medical attention at the center of reproduction. Methods. The full-design descriptive two-phase study was conducted. Patients with PCOS (ESHRE/ASRM) seeking medical attention at the center of reproduction were examined by a psychiatrist, and 2 years later they were re-interviewed. The qualification of the condition was carried out on the basis of a clinical conversation in accordance with the ICD-10 criteria. Results. 116 patients of reproductive age were examined. Mental disorders were found in 76 (65.5%) women, 45 of them (38.8%) had mood disorders (affective disorders). 63 (54.3%) women took part in the second stage of study; 30 (47.6%) of them had a pregnancy ended in childbirth during the control period. Among 26 women diagnosed with the first stage of mood disorders, 18 (69.2%) had a relapse within two years. 15 women had a manifestation of depression in the same period. At least one episode of depression was detected in the same period in 15 patients who became pregnant for two years, 10 of them had depression in the postpartum period (33.3%, n=30). Conclusion. Patients with PCOS are highly susceptible to depression, characterized by a relapsing course and a tendency to increase in incidence over time. There is a high incidence of postpartum depression. All above mentioned demonstrates the need to develop approaches to the management of women with PCOS by multidisciplinary teams.

Full Text

Restricted Access

About the authors

N. A Ilina

V.P. Serbsky National Medical Research Center of Psychiatry and Narcology

Email: bobrovanadia@gmail.com
Ilyina, Postgraduate Student at the Department of Psychological Counseling and Psychotherapy 23, Kropotkinsky Pereulok, Moscow 119034, Russian Federation

T. V Dovzhenko

V.P. Serbsky National Medical Research Center of Psychiatry and Narcology

Moscow, Russia

E. E Grodnitskaya

Centre for Family Planning and Reproduction

Moscow, Russia

References

  1. March W.A., Moore V.M., Willson K.J., et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:2:544-51. doi: 10.1093/humrep/dep399.
  2. Moran C., Tena G., Moran S., et al. Prevalence of polycystic ovary syndrome and related disorders in mexican women. Gynecol Obstet Invest. 2010;69:4:274-80. doi: 10.1159/000277640.
  3. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.
  4. Shorakae S, Boyle J., Teede H. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about. Intern Med J. 2014;44(8):720-26.
  5. Чернуха Г.Е. Современные представления о синдроме поликистозных яичников. Consilium Medicum. 2002;4(10):16-9.
  6. Организация Объединенных Наций (1995). Доклад Международной конференции по народонаселению и развитию. Каир, 5-13 сентября 1994. A/CONF.171/13/Rev.1
  7. Barry J.A., Kuczmierczyk A.R., Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442-51.
  8. Benson S., Janssen O.E., Hahn S., et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun. 2008;22(2):177-84.
  9. Cesta C.E., Mansson M., Palm C., et al. Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology. 2016;73:196-doi: 10.1016/j.psyneuen.2016.08.005.
  10. International evidencebased guideline for the assessment and management of polycystic ovary syndrome. Copyright Monash University, Melbourne Australia 2018.
  11. Clinical Management Guidelines for Obstetrician-Gynecologists Use of Psychiatric Medications During Pregnancy and Lactation. ACOG Practice Bulletin focus. 2009;7(3):385-400. http://dx.doi. org/10.1176/foc.7.3.foc385.
  12. Ушкалова Е.А., Ушкалова А.В., Шифман Е.М. Фармакотерапия депрессивных расстройств в период беременности и грудного вскармливания: методические рекомендации. М., 2012. 61 c.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies